PROVIDER PROFILE · NPI 1003832304

Prabha RanganathanMD

RheumatologySaint Louis, MOI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

353

Unique beneficiaries

—

Total services

496

Distinct HCPCS

Medicare payment

$30K

Peer benchmark

Total Medicare services vs. 94 Rheumatology providers in MO — above median (cohort median 1,226).

PRESCRIBING · PART D · 2024

Total Rx claims

895

Beneficiaries

—

Total drug cost

$1.8M

Distinct drugs

Brand share

50.4%

Top prescribed drugs

Methotrexate Sodium221 claims

Hydroxychloroquine Sulfate107 claims

Prednisone84 claims

Leflunomide70 claims

Adalimumab68 claims

QUALITY · MIPS · 2024

Final MIPS score

84.2

Quality

71.6

Cost

75.7

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.39%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$121

Payment records

By payment type

Food and Beverage$62

Education$59

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (4)

Hospital

Hospital

Hospital

Hospital

REFERRAL NETWORK

Where Prabha Ranganathan's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 5 outbound destinations.

Receives referrals from

Inbound — who sends patients here

No inbound pairs above the suppression threshold.

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
BARNES JEWISH HOSPITAL	107	283
Richard Ostlund Endocrinology · Saint Louis, MO	84	134
BARNES JEWISH WEST COUNTY HOSPITAL	50	123
FRASER, VICTORIA	45	58
Labone Llc Clinical Laboratory · Lenexa, KS	21	32

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history